{
    "organizations": [],
    "uuid": "9c899395a1a27826ce33a5a2b2f276a511801c83",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ortho-dermatologics-announces-us-f/brief-ortho-dermatologics-announces-u-s-fda-filing-acceptance-for-idp-121-idUSASB0C0SZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 12 (Reuters) - Valeant Pharmaceuticals International Inc :\n* ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM\n* ORTHO DERMATOLOGICS - PDUFA ACTION DATE IS AUG. 27, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-12T20:06:00.000+02:00",
    "crawled": "2018-01-13T14:45:06.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "ortho",
        "dermatologics",
        "announces",
        "fda",
        "filing",
        "acceptance",
        "acne",
        "treatment",
        "lotion",
        "form",
        "ortho",
        "dermatologics",
        "pdufa",
        "action",
        "date",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}